Literature DB >> 18400364

Early fetal gene delivery utilizes both central and peripheral mechanisms of tolerance induction.

Evan Colletti1, Sean Lindstedt, Paul J Park, Graça Almeida-Porada, Christopher D Porada.   

Abstract

OBJECTIVE: We previously reported the induction of stable immune tolerance following direct injection of retroviral vectors into preimmune fetal sheep. In the present studies, we conduct detailed analysis of the thymus of recipients of in utero gene transfer (IUGT) to delineate the mechanism of the observed immune tolerance and assess the impact of recipient age on this process.
MATERIALS AND METHODS: Fetal sheep at varying gestational ages received the MSCV-NeoR-RFP retroviral vector. The thymus was then collected from these animals at 27 to 30 days postinjection and analyzed for evidence of transduction of key immunoregulatory thymic cells.
RESULTS: Our results reveal that both thymic epithelial cells (TEC), crucial for presentation of self-antigen during T-cell thymic selection, and the cells comprising the Hassall's corpuscles, which can present antigen directly and also instruct dendritic cells to induce the formation of CD4(+)CD25(+) T-regulatory cells in the thymus, were only efficiently transduced if IUGT was performed early in gestation.
CONCLUSIONS: Our findings thus demonstrate, for the first time, that early IUGT can potentially take advantage of multiple tolerogenic avenues in the fetus, transducing both TEC, which promote central tolerance, and Hassall's corpuscles, which induce formation of T regulatory cells that could act to maintain peripheral tolerance to the transgene products.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18400364      PMCID: PMC2486147          DOI: 10.1016/j.exphem.2008.02.007

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  28 in total

1.  Maternal undernutrition from early- to mid-gestation leads to growth retardation, cardiac ventricular hypertrophy, and increased liver weight in the fetal sheep.

Authors:  Kimberly A Vonnahme; Bret W Hess; Thomas R Hansen; Richard J McCormick; Daniel C Rule; Gary E Moss; William J Murdoch; Mark J Nijland; Donal C Skinner; Peter W Nathanielsz; Stephen P Ford
Journal:  Biol Reprod       Date:  2003-02-19       Impact factor: 4.285

2.  In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor.

Authors:  Simon N Waddington; Suzanne M K Buckley; Megha Nivsarkar; Sarah Jezzard; Holm Schneider; Thomas Dahse; Geoff Kemball-Cook; Maznu Miah; Nick Tucker; Margaret J Dallman; Mike Themis; Charles Coutelle
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

3.  Widespread and efficient marker gene expression in the airway epithelia of fetal sheep after minimally invasive tracheal application of recombinant adenovirus in utero.

Authors:  D Peebles; L G Gregory; A David; M Themis; S N Waddington; H J Knapton; M Miah; T Cook; L Lawrence; M Nivsarkar; C Rodeck; C Coutelle
Journal:  Gene Ther       Date:  2004-01       Impact factor: 5.250

4.  In utero gene therapy: transfer and long-term expression of the bacterial neo(r) gene in sheep after direct injection of retroviral vectors into preimmune fetuses.

Authors:  C D Porada; N Tran; M Eglitis; R C Moen; L Troutman; A W Flake; Y Zhao; W F Anderson; E D Zanjani
Journal:  Hum Gene Ther       Date:  1998-07-20       Impact factor: 5.695

5.  Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy.

Authors:  Simon N Waddington; Megha S Nivsarkar; Ajay R Mistry; Suzanne M K Buckley; Geoffrey Kemball-Cook; Karen L Mosley; Kyriacos Mitrophanous; Pippa Radcliffe; Maxine V Holder; Mairi Brittan; Anastasios Georgiadis; Faisal Al-Allaf; Brian W Bigger; Lisa G Gregory; H Terence Cook; Robin R Ali; Adrian Thrasher; Edward G D Tuddenham; Mike Themis; Charles Coutelle
Journal:  Blood       Date:  2004-07-01       Impact factor: 22.113

6.  Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.

Authors:  Vassili Soumelis; Pedro A Reche; Holger Kanzler; Wei Yuan; Gina Edward; Bernhart Homey; Michel Gilliet; Steve Ho; Svetlana Antonenko; Annti Lauerma; Kathleen Smith; Daniel Gorman; Sandra Zurawski; Jon Abrams; Satish Menon; Terri McClanahan; Rene de Waal-Malefyt Rd; Fernando Bazan; Robert A Kastelein; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2002-06-10       Impact factor: 25.606

7.  Effects of three courses of maternally administered dexamethasone at 0.7, 0.75, and 0.8 of gestation on prenatal and postnatal growth in sheep.

Authors:  Michelle A Kutzler; Erin K Ruane; Turhan Coksaygan; Stella E Vincent; Peter W Nathanielsz
Journal:  Pediatrics       Date:  2004-02       Impact factor: 7.124

8.  Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T cell homeostatic expansion.

Authors:  Norihiko Watanabe; Shino Hanabuchi; Vassili Soumelis; Wei Yuan; Stephen Ho; Rene de Waal Malefyt; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2004-02-29       Impact factor: 25.606

9.  Proinsulin expression by Hassall's corpuscles in the mouse thymus.

Authors:  Aziz Alami Chentoufi; Michael Palumbo; Constantin Polychronakos
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

Review 10.  The sheep model of in utero gene therapy.

Authors:  Christopher D Porada; Paul Park; Graça Almeida-Porada; Esmail D Zanjani
Journal:  Fetal Diagn Ther       Date:  2004 Jan-Feb       Impact factor: 2.587

View more
  10 in total

1.  In utero transplantation: Disparate ramifications.

Authors:  John S Pixley; Esmail D Zanjani
Journal:  World J Stem Cells       Date:  2013-04-26       Impact factor: 5.326

2.  Gene therapy: the promise of a permanent cure.

Authors:  Christopher D Porada; Christopher Stem; Graca Almeida-Porada
Journal:  N C Med J       Date:  2013 Nov-Dec

3.  Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A.

Authors:  Christopher Stem; Christopher Rodman; Ritu M Ramamurthy; Sunil George; Diane Meares; Andrew Farland; Anthony Atala; Christopher B Doering; H Trent Spencer; Christopher D Porada; Graça Almeida-Porada
Journal:  Front Cell Dev Biol       Date:  2021-08-10

4.  Fetal Gene Therapy Using a Single Injection of Recombinant AAV9 Rescued SMA Phenotype in Mice.

Authors:  Afrooz Rashnonejad; Gholamhossein Amini Chermahini; Cumhur Gündüz; Hüseyin Onay; Ayça Aykut; Burak Durmaz; Meral Baka; Qin Su; Guangping Gao; Ferda Özkınay
Journal:  Mol Ther       Date:  2019-08-31       Impact factor: 11.454

5.  Mesenchymal stem cells contribute to endogenous FVIII:c production.

Authors:  Chad Sanada; Chung-Jung Kuo; Evan J Colletti; Melisa Soland; Saloomeh Mokhtari; Mary Ann Knovich; John Owen; Esmail D Zanjani; Christopher D Porada; Graça Almeida-Porada
Journal:  J Cell Physiol       Date:  2013-05       Impact factor: 6.384

Review 6.  Delivery technologies for in utero gene therapy.

Authors:  Rohan Palanki; William H Peranteau; Michael J Mitchell
Journal:  Adv Drug Deliv Rev       Date:  2020-11-09       Impact factor: 15.470

7.  Mechanistic Insights into Factor VIII Immune Tolerance Induction via Prenatal Cell Therapy in Hemophilia A.

Authors:  Martin Rodriguez; Christopher D Porada; Graҫa Almeida-Porada
Journal:  Curr Stem Cell Rep       Date:  2019-11-20

8.  Pseudotyped AAV vector-mediated gene transfer in a human fetal trachea xenograft model: implications for in utero gene therapy for cystic fibrosis.

Authors:  Sundeep G Keswani; Swathi Balaji; Louis Le; Alice Leung; Anna B Katz; Foong-Yen Lim; Mounira Habli; Helen N Jones; James M Wilson; Timothy M Crombleholme
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

Review 9.  Hemophilia A: an ideal disease to correct in utero.

Authors:  Christopher D Porada; Christopher Rodman; Glicerio Ignacio; Anthony Atala; Graça Almeida-Porada
Journal:  Front Pharmacol       Date:  2014-12-11       Impact factor: 5.810

Review 10.  In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application.

Authors:  Graça Almeida-Porada; Anthony Atala; Christopher D Porada
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-30       Impact factor: 6.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.